Online citations, reference lists, and bibliographies.
← Back to Search

A Practical Approach To The Management Of Cerebral Amyloid Angiopathy

M. Kozberg, V. Perosa, M. Gurol, S. V. van Veluw
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Cerebral amyloid angiopathy is a common small vessel disease in the elderly involving vascular amyloid-β deposition. Cerebral amyloid angiopathy is one of the leading causes of intracerebral hemorrhage and a significant contributor to age-related cognitive decline. The awareness of a diagnosis of cerebral amyloid angiopathy is important in clinical practice as it impacts decisions to use lifelong anticoagulation or nonpharmacological alternatives to anticoagulation such as left atrial appendage closure in patients who have concurrent atrial fibrillation, another common condition in older adults. This review summarizes the latest literature regarding the management of patients with sporadic cerebral amyloid angiopathy, including diagnostic criteria, imaging biomarkers for cerebral amyloid angiopathy severity, and management strategies to decrease intracerebral hemorrhage risk. In a minority of patients, the presence of cerebral amyloid angiopathy triggers an autoimmune inflammatory reaction, referred to as cerebral amyloid angiopathy-related inflammation, which is often responsive to immunosuppressive treatment in the acute phase. Diagnosis and management of cerebral amyloid angiopathy-related inflammation will be presented separately. While there are currently no effective therapeutics available to cure or halt the progression of cerebral amyloid angiopathy, we discuss emerging avenues for potential future interventions.
This paper references
10.2214/AJR.149.2.351
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.
F. Fazekas (1987)
F Fazekas (1987)
10.1002/ANA.410380219
Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy
S. Greenberg (1995)
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.
S. Greenberg (1995)
10.1212/WNL.50.4.961
Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
S. Greenberg (1998)
Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.
S. Greenberg (1998)
Alzheimer's disease and related disorders annual
S. Gautier (2000)
10.1212/WNL.54.12.2298
Aspirin-associated intracerebral hemorrhage
K. Wong (2000)
10.1212/WNL.56.4.537
Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
K. Knudsen (2001)
10.1093/JNEN/61.3.282
Two Types of Sporadic Cerebral Amyloid Angiopathy
D. Thal (2002)
10.1212/01.WNL.0000073623.84147.A8
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
J. Orgogozo (2003)
10.1212/01.WNL.0000046583.40125.20
Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages
K. Wong (2003)
10.1038/nm840
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
J. Nicoll (2003)
10.1001/ARCHINTE.164.8.880
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.
J. Rosand (2004)
10.1161/01.STR.0000143224.36527.44
Amyloid Angiopathy–Related Vascular Cognitive Impairment
S. Greenberg (2004)
10.1212/01.WNL.0000142966.22886.20
White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage
E. Smith (2004)
10.1002/ana.20571
A novel AβPP mutation exclusively associated with cerebral amyloid angiopathy
L. Obici (2005)
10.1002/ana.20596
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy
J. Rosand (2005)
10.1212/01.WNL.0000159740.16984.3C
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S. Gilman (2005)
A novel AbPP mutation exclusively associated with cerebral amyloid angiopathy
L Obici (2005)
GAG mimetics in Alzheimer’s disease
F Gervais (2005)
F Gervais (2005)
10.1056/NEJMOA061894
High-dose atorvastatin after stroke or transient ischemic attack.
P. Amarenco (2006)
10.1212/01.wnl.0000191403.95453.6a
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
M. Gurol (2006)
10.1002/ana.20778
Suppression of cortical spreading depression in migraine prophylaxis
C. Ayata (2006)
10.1097/01.wad.0000213845.28624.f4
A Phase 2 Study of Tramiprosate for Cerebral Amyloid Angiopathy
S. Greenberg (2006)
Plasma betaamyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
ME Gurol (2006)
A phase 2 study of tramiprosate for cerebral amyloid angiopa
SM Greenberg (2006)
Highdose atorvastatin after stroke or transient ischemic attack
P Amarenco (2006)
10.1212/01.wnl.0000260066.98681.2e
Course of cerebral amyloid angiopathy–related inflammation
C. Kinnecom (2007)
10.1161/STROKEAHA.107.487090
Risk Factors for Intracerebral Hemorrhage in a Pooled Prospective Study
Jared D. Sturgeon (2007)
10.1016/J.AMJMED.2006.07.034
Death and disability from warfarin-associated intracranial and extracranial hemorrhages.
M. Fang (2007)
10.1007/S11883-008-0050-Y
Management of intracerebral hemorrhage
M. Gurol (2008)
10.1212/01.wnl.0000345666.83318.03
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy
W. Kimberly (2009)
10.1056/NEJMoa0905561
Dabigatran versus warfarin in patients with atrial fibrillation.
S. Connolly (2009)
10.1001/archneurol.2009.42
Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study.
M. Vernooij (2009)
10.1161/CIRCULATIONAHA.108.795666
Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage: The Ibaraki Prefectural Health Study
H. Noda (2009)
10.1002/ana.21694
Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy
M. Verbeek (2009)
10.1212/WNL.0b013e3181eee40f
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy
A. Biffi (2010)
10.1212/WNL.0b013e3181f002c1
Prevalence of Superficial Siderosis in Patients with Cerebral Amyloid Angiopathy
H-L Zhang (2010)
10.1016/S1474-4422(09)70340-0
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis
C. V. Asch (2010)
10.1161/STROKEAHA.109.563932
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
H. Arima (2010)
10.1002/ana.22134
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage
A. Biffi (2010)
10.1378/chest.09-1584
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
G. Lip (2010)
10.1136/jnnp.2009.204180
Cerebral amyloid angiopathy related inflammation: three case reports and a review
K. Chung (2010)
10.3988/jcn.2011.7.1.1
Cerebral Amyloid Angiopathy: A Systematic Review
A. Biffi (2011)
10.1056/NEJMoa1107039
Apixaban versus warfarin in patients with atrial fibrillation.
C. Granger (2011)
10.1038/jcbfm.2010.191
Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain Injury
M. Lauritzen (2011)
10.1016/j.jalz.2011.05.2351
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
R. Sperling (2011)
10.1002/ana.22516
Cerebral amyloid angiopathy in the elderly
A. Viswanathan (2011)
10.1016/j.jtcvs.2011.07.052
Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.
G. Ailawadi (2011)
10.1016/S1474-4422(10)70325-2
Apolipoprotein E in Alzheimer's disease and other neurological disorders
P. Verghese (2011)
10.1056/NEJMoa1009638
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Manesh R Patel (2011)
Roles of apolipoprotein E in Alzheimer’s disease and other neurological disorders
P Verghese (2011)
10.1016/S1474-4422(11)70307-6
Cerebral microinfarcts: the invisible lesions
Eric E. Smith (2012)
10.1161/STROKEAHA.112.657759
Spectrum of Transient Focal Neurological Episodes in Cerebral Amyloid Angiopathy: Multicentre Magnetic Resonance Imaging Cohort Study and Meta-Analysis
A. Charidimou (2012)
10.1161/STROKEAHA.112.658369
Different Impacts of Blood Pressure Variability on the Progression of Cerebral Microbleeds and White Matter Lesions
Wenhong Liu (2012)
10.1007/s11886-013-0425-8
Cerebral Microbleeds and Macrobleeds: Should They Influence Our Recommendations for Antithrombotic Therapies?
Kellen E Haley (2013)
10.1161/CIRCULATIONAHA.112.114389
Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial
V. Reddy (2013)
10.1002/ana.23857
Anti–amyloid β autoantibodies in cerebral amyloid angiopathy–related inflammation: Implications for amyloid‐modifying therapies
F. Piazza (2013)
10.1002/ANA.23830
Cerebral Amyloid Angiopathy Burden Associated with Leukoaraiosis:a PET/MRI Study
M. Gurol (2013)
10.1002/ana.23891
Inflammatory cerebral amyloid angiopathy and amyloid‐modifying therapies: Variations on the Same ARIA?
D. Werring (2013)
10.1186/1129-2377-14-62
Cortical spreading depression as a target for anti-migraine agents
C. Costa (2013)
10.1056/NEJMoa1310907
Edoxaban versus warfarin in patients with atrial fibrillation.
R. Giugliano (2013)
10.1212/WNL.0b013e3182a9f545
A&bgr;-related angiitis: Comparison with CAA without inflammation and primary CNS vasculitis
C. Salvarani (2013)
10.1016/j.jacc.2013.03.035
Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
V. Reddy (2013)
10.1161/STROKEAHA.114.005151
Incidence of Symptomatic Hemorrhage in Patients With Lobar Microbleeds
Ellis S. van Etten (2014)
10.1212/WNL.0000000000000732
Posterior white matter disease distribution as a predictor of amyloid angiopathy
Sekh Thanprasertsuk (2014)
10.1016/j.jacc.2014.04.029
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
D. Holmes (2014)
10.1007/s00234-014-1330-6
Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome
M. Martucci (2014)
10.3389/fnagi.2014.00187
Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
R. Marr (2014)
10.1016/j.semarthrit.2014.02.001
Amyloid beta-related angiitis--a case report and comprehensive review of literature of 94 cases.
A. Danve (2014)
RA Marr (2014)
10.1001/jama.2015.10082
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
A. Biffi (2015)
10.1016/j.addr.2015.03.008
Antisense oligonucleotides in therapy for neurodegenerative disorders.
M. Evers (2015)
10.1161/CIRCULATIONAHA.115.016261
Cerebral Microbleeds Are Associated With an Increased Risk of Stroke: The Rotterdam Study
Saloua Akoudad (2015)
10.1212/WNL.0000000000001398
Cerebral amyloid angiopathy with and without hemorrhage
A. Charidimou (2015)
10.1007/s11883-015-0526-5
Statins in Intracerebral Hemorrhage
A. Lauer (2015)
10.1093/brain/awu316
Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.
Y. Reijmer (2015)
10.3233/JAD-150070
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network.
J. C. DiFrancesco (2015)
10.1161/STROKEAHA.115.010024
Inflammatory Cerebral Amyloid Angiopathy, Amyloid-β-Related Angiitis, and Primary Angiitis of the Central Nervous System: Similarities and Differences.
A. Moussaddy (2015)
Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease
A Charidimou (2015)
10.1212/WNL.0000000000002362
White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy
A. Charidimou (2016)
10.1038/nature19323
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
J. Sevigny (2016)
10.1038/jcbfm.2015.88
Ischemic brain injury in cerebral amyloid angiopathy
Y. Reijmer (2016)
10.2147/CPAA.S105165
Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation
A. Tawfik (2016)
10.1097/MD.0000000000003613
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy–Related Inflammation
C. Salvarani (2016)
10.1001/jamaneurol.2015.4078
Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation.
E. Auriel (2016)
10.3233/JAD-151036
Cerebral Amyloid Angiopathy (CAA)-Related Inflammation: Comparison of Inflammatory CAA and Amyloid-β-Related Angiitis.
Shuguang Chu (2016)
10.1093/BRAIN/AWW229
Microbleed and microinfarct detection in amyloid angiopathy: a high-resolution MRI-histopathology study.
S. V. van Veluw (2016)
10.1161/STROKEAHA.115.011627
Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study
A. Saxena (2016)
10.1212/WNL.0000000000003197
Florbetapir-PET to diagnose cerebral amyloid angiopathy
M. Gurol (2016)
10.1161/STROKEAHA.115.007958
Molecular Neuroimaging in Vascular Cognitive Impairment.
M. Gurol (2016)
10.1016/S1474-4422(16)30030-8
Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study
P. Fotiadis (2016)
Cerebral amyloid angiopathy (CAA)-related inflammation: International Journal of Stroke, 16(4) 368 International Journal of Stroke 16(4) comparison of inflammatory CAA and amyloid-brelated angiitis
S Chu (2016)
Cerebral amyloid angiopathy (CAA)-related inflammation: comparison of inflammatory CAA and amyloid-brelated angiitis
S Chu (2016)
A Tawfik (2016)
Imaging findings of cerebral amyloid angiopathy, Ab-related angiitis (ABRA), and cerebral amyloid angiopathy-related inflammation: a single-institution 25-year experience
C Salvarani (2016)
10.1016/j.hrthm.2017.05.038
Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
L. Boersma (2017)
10.1016/S1474-4422(17)30196-5
Detection, risk factors, and functional consequences of cerebral microinfarcts
S. V. Veluw (2017)
10.1212/WNL.0000000000003746
MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy
A. Charidimou (2017)
10.1212/WNL.0000000000003486
&bgr;-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy
Ellis S. van Etten (2017)
10.1212/WNL.0000000000004007
Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease
M. Pasi (2017)
10.1097/HJH.0000000000001159
Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis
Jian-qi Wang (2017)
10.1177/0271678X16685573
Functional deficits induced by cortical microinfarcts
P. Summers (2017)
10.1212/WNL.0000000000004228
Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages
N. Raposo (2017)
10.1212/WNL.0000000000004665
Cortical superficial siderosis multifocality in cerebral amyloid angiopathy
A. Charidimou (2017)
10.1016/j.blre.2017.07.006
Diagnosis and management of the antiphospholipid syndrome.
Shruti Chaturvedi (2017)
10.1161/HYPERTENSIONAHA.117.09479
Blood Pressure Trajectories and the Risk of Intracerebral Hemorrhage and Cerebral Infarction: A Prospective Study
Weijuan Li (2017)
bAmyloid in CSF: biomarker for preclinical cerebral amyloid angiopathy
ES Van Etten (2017)
10.1161/STROKEAHA.117.019189
Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk
C. Jin (2018)
10.1016/S1474-4422(18)30145-5
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study
Duncan Wilson (2018)
10.1161/STROKEAHA.117.017081
Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk
M. Gurol (2018)
10.1111/ene.13484
Cortical superficial siderosis and acute convexity subarachnoid hemorrhage in cerebral amyloid angiopathy
N. Raposo (2018)
10.1161/STROKEAHA.118.022280
Cerebral Cortical Microinfarcts on Magnetic Resonance Imaging and Their Association With Cognition in Cerebral Amyloid Angiopathy
L. Xiong (2018)
10.1161/STROKEAHA.118.021539
Distribution of Lacunar Infarcts in Asians With Intracerebral Hemorrhage: A Magnetic Resonance Imaging and Amyloid Positron Emission Tomography Study
Hsin-Hsi Tsai (2018)
10.1212/WNL.0000000000005898
Cholesterol levels, statins, and spontaneous intracerebral hemorrhage
G. Falcone (2018)
10.1007/s11910-018-0813-y
Atrial Fibrillation for the Neurologist: Preventing both Ischemic and Hemorrhagic Strokes
Elif Gokcal (2018)
10.1212/WNL.0000000000005030
Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy
A. Charidimou (2018)
10.1177/1747493017741569
Cerebral amyloid angiopathy associated with inflammation: A systematic review of clinical and imaging features and outcome
A. Ćorović (2018)
10.1212/WNL.0000000000005907
Association of statin use with spontaneous intracerebral hemorrhage
W. Saliba (2018)
Cerebral cortical microinfarcts on MRI and their association with cognition in cerebral amyloid angiopathy
L Xiong (2018)
10.1007/s10840-019-00678-w
WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage
W. Hucker (2019)
10.1212/WNL.0000000000007495
Insights into the pathogenesis of normal-pressure hydrocephalus
S. Spina (2019)
10.1038/s41582-019-0281-2
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
S. Greenberg (2019)
10.1161/STROKEAHA.119.026235
Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study.
Hsin-Hsi Tsai (2019)
10.1212/WNL.0000000000007005
Histopathology of diffusion imaging abnormalities in cerebral amyloid angiopathy
S. V. van Veluw (2019)
10.1002/acn3.761
Immunotherapy with ponezumab for probable cerebral amyloid angiopathy
C. Leurent (2019)
10.1161/STROKEAHA.119.024149
Advanced Neuroimaging to Unravel Mechanisms of Cerebral Small Vessel Diseases.
M. Gurol (2019)
10.1093/brain/awz142
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease
J. Nicoll (2019)
10.1002/ana.25512
Different microvascular alterations underlie microbleeds and microinfarcts
S. V. van Veluw (2019)
10.1212/WNL.0000000000007818
APOE and cortical superficial siderosis in CAA
A. Charidimou (2019)
10.1126/science.aax5440
Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep
Nina E. Fultz (2019)
10.1212/WNL.0000000000007853
Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage
Chaoran Ma (2019)
10.1002/ana.25560
Amyloid imaging of dutch‐type hereditary cerebral amyloid angiopathy carriers
A. Schultz (2019)
10.4244/EIJ-D-19-00128
Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study.
A. Cresti (2019)
10.1212/WNL.0000000000007532
MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation
J. Martí-Fàbregas (2019)
10.1111/pace.13796
A comparison of postprocedural anticoagulation in high‐risk patients undergoing WATCHMAN device implantation
Joshua A Cohen (2019)
10.1177/1747493019855888
Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0
A. Charidimou (2019)
10.1161/STR.0000000000000195
Correction to: Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging and Pathology-Based Study.
(2019)
10.1016/j.jacc.2019.03.010
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
D. Arnett (2019)
10.1161/STROKEAHA.119.024843
Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy.
M. Pasi (2019)
10.1016/S0140-6736(19)30840-2
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
Rustam MS PAG CLM JM WN GD J DE N DJ PM Colin Daniel Fran Al-Shahi Salman Dennis Sandercock Sudlow Wardlaw W (2019)
SJ vanVeluw (2019)
Prevalence of extra-appendage thrombosis
A Cresti (2019)
ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines
DK Arnett (2019)
Interrelationship between lacunes and cortical microinfarcts in cerebral amyloid angiopathy
E Gokcal (2019)
10.1016/j.jacc.2020.04.067
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
P. Osmancik (2020)
10.1212/NXG.0000000000000411
Hereditary cerebral amyloid angiopathy, Piedmont-type mutation
M. Kozberg (2020)
10.1093/brain/awaa266
Neuropathological correlates of cortical superficial siderosis in cerebral amyloid angiopathy.
A. Charidimou (2020)
10.1161/STROKEAHA.120.028310
Combining Imaging and Genetics to Predict Recurrence of Anticoagulation-Associated Intracerebral Hemorrhage
A. Biffi (2020)
10.1016/j.neuron.2019.10.033
Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain
S. V. Veluw (2020)
10.1038/s41582-020-0312-z
Perivascular spaces in the brain: anatomy, physiology and pathology
J. Wardlaw (2020)
10.1001/jamaneurol.2020.1782
Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy-Related Inflammation.
R. Regenhardt (2020)
10.1212/WNL.0000000000009321
Cortical superficial siderosis progression in cerebral amyloid angiopathy
Thanakit Pongpitakmetha (2020)
10.1212/wnl.0000000000010017
White matter atrophy in cerebral amyloid angiopathy
P. Fotiadis (2020)
10.1001/jamaneurol.2020.1512
Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016.
V. Lioutas (2020)
non - valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion : a large transoeso - phageal echo study
DR Holmes
A Charidimou
Interrelationship between lacunes and cortical microinfarcts in cerebral amyloid angiopathy. In: Oral presentation
E Gokcal
WJ Hucker



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar